Close Menu

NEW YORK (GenomeWeb) – MDxHealth announced today that it has signed a worldwide licensing agreement with Philips for the rights to manufacture and market Philips' recently validated phosphodiesterase-4D7 prostate cancer biomarker as a prognostic test.

The financial terms of the agreement have not been disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The nonprofit Biden Cancer Initiative is suspending its operations, according to the Associated Press.

Researchers examine how white nationalists handle personal genetic ancestry results that conflict with their racist worldview, the New York Times reports.

NPR speaks with research participants before and after they learn their APOE E4 status, which affects their risk of developing Alzheimer's disease.

In PLOS this week: genetic characterization of Toxoplasma gondii strains, Crimean-Congo Hemorrhagic Fever Virus uncovered in Sudan, and more.